ARTICLE
Linear atrophoderma of Moulin is a rare entity first described by Moulin
in 1992 [1]. It is characterized by asymptomatic hyperpigmented atrophic
band-like lesions localized mostly on the trunk and following the lines
of Blaschko. Baumann et al. [2] suggested the term "linear atrophoderma
of Moulin" for these band-like scleroderma-like skin lesions that do not
show a preceding inflammation or induration. They categorized this disease
as belonging to the group of acquired linear dermatoses following Blaschko's
lines. The skin lesions usually first appear during childhood and adolescence
and subsequently remain unchanged.
To date, 9 cases of linear atrophoderma of Moulin have been reported
[1-5]. In addition, two cases reported under another diagnosis can today
be assigned to this disorder [6-8]. We report a further typical case of
this so far poorly-known clinical entity.
Case report
In January 1998, a 17-year-old woman was referred to the Department
of Dermatology, Klinikum Kassel, Germany, with a 3-year history of an
asymptomatic linear skin lesion affecting the right side of her trunk.
The lesion first appeared on the back and gradually extended to the anterior
midline. After a short period of rapid enlargement, the skin disorder
remained unchanged.
Physical examination showed a hyperpigmented and atrophic band-like
skin lesion measuring 3-5 cm in breadth on the right side of the trunk
(Fig. 1), and another
one on the right buttock. Both streaks started a few cm from the posterior
midline and followed Blaschko's lines. The skin lesions had a normal texture
and showed no signs of inflammation such as lilac ring or erythema, and
no induration or sclerosis.
Laboratory findings including a test for Borrelia burgdorferi antibodies
were normal except for elevated serum IgE (197 kU/l). Antinuclear antibodies
(ANA) and anti-Scl70-antibodies were negative. Chest X-ray and ultrasound
examination of the abdomen gave normal results.
A skin biopsy was taken from the marginal zone of the skin lesion. Histopathological
examination showed a moderate diffuse hyperpigmentation within the lower
part of the epidermis and a focal vacuolar degeneration of the basal layer
(Fig. 2). In these areas
hyalin eosinophilic units, reminiscent of Civatte bodies were found. In
the dermis, melanin-laden macrophages and a few perivascular lymphocytes
were present. The collagen bundles appeared to be slightly thickened,
whereas the elastic fibres were unchanged (Fig.
3).
Penicillin G was administered intravenously over a period of 14 days
in a dosage of 10 x 106 IU twice daily. This treatment was
repeated after 3 and 9 months. No improvement was noted.
Discussion
Linear atrophoderma as described by Moulin et al. in 1992 [1]
is an acquired disorder characterized by the rather sudden appearance
of hyperpigmented atrophic band-like skin lesions in otherwise healthy
children or young adults. The lesions are localized on the trunk or the
limbs. They start a few centimeters from the posterior midline and follow
Blaschko's lines. There is no inflammation, induration, scleroderma or
epidermal atrophy. Usually the lesions remain stable in localisation,
color and size. There are no subjective symptoms. No other abnormalities
have been described to be associated with this skin disorder [1-5].
The individual skin lesions of linear atrophoderma of Moulin closely
resemble those of atrophodermia idiopathica of the Pasini and Pierini
type (AIPP) which however, never follow Blaschko's lines. Retrospectively,
at least two cases as described in the literature can be assigned to linear
atrophoderma of Moulin [6-8]. It is so far a controversial issue whether
linear atrophoderma of Moulin represents a distinct entity or a clinical
variant of AIPP [2]. AIPP itself has been discussed controversially as
either a separate disorder or a variant of circumscribed scleroderma [9-18].
In skin biopsies of linear atrophoderma of Moulin, an irregular and
moderate hyperpigmentation of the lower part of the epidermis is found.
The dermis is unaffected except for the inconstant presence of a slight
perivascular lymphocytic infiltrate. Occasionally, a collagen sclerosis
can be observed [4]. The presence of hyalin eosinophilic units within
the basal epidermal layers, reminiscent of civatte bodies as known from
lichen planus, is an occasional and non-specific finding (Fig.
2).
Moulin et al. did not detect abnormal
laboratory findings [1]. Antinuclear antibodies have been reported in
one case of linear atrophoderma of Moulin only [2], but the significance
of this finding is uncertain. Similarly, the implication of laboratory
abnormalities - especially ANA - in circumscribed scleroderma and AIPP,
is a controversial issue. In our case, the results of laboratory analysis
were normal except for a slight elevation of serum IgE which should be
taken as a coincidental finding.
Linear atrophoderma Moulin should be discriminated from other disorders
that show similar configuration, atrophy and hyperpigmentation. AIPP is
a rare form of dermal atrophy of unclear cause. This disease is characterized
by the appearance of circumscribed, reddish-brown atrophic lesions without
preceding inflammation on otherwise normal skin. The lesions are observed
in adults as well as children and are otherwise asymptomatic. However,
these lesions tend to show signs of changes such as confluence and enlargement
[14, 17]. Several authors reported subsequent induration or sclerosis
of the lesions [17, 18]. Most patients with AIPP show a bilateral symmetric
distribution, usually orientated along the skin cleavage lines [12, 16],
but a unilateral involvement has likewise been reported [9]. However,
AIPP does not follow the pattern of Blaschko's lines. On the other hand,
a large variety of skin diseases follow Blaschko's lines, e.g.,
incontinentia pigmenti, Goltz syndrome, lichen striatus and pigmentary
mosaicism of the Ito type [19-23]. In our patient, the initial clinical
diagnosis was linear scleroderma. However, the impressive configuration
of the skin lesions and the absence of inflammation, sclerosis or induration
led to a diagnosis of linear atrophoderma of Moulin.
The etiology and pathogenesis of the disorder
remains unknown. All reported cases were so far sporadic. The disorder
may illustrate a clonal proliferation of mutant cells during embryogenesis
[1, 2, 23]. This clone of mesodermal origin may be characterized by an
aberrant pattern of tissue antigens giving rise to a selective autoimmune
attack later in life. If this concept holds true, linear atrophoderma
of Moulin would be an additional argument against the hypothesis that
the lines of Blaschko are exclusively of ectodermal origin [24].
Topical treatments with steroids or heparin showed no effect in linear
atrophoderma of Moulin [2]. Igarza et al. treated a 16-year-old
girl by oral potassium aminobenzoate and described an "early stabilization
of the skin lesions" [4]. Treatment with UV-light has shown improvement
in some patients whereas aggravation was seen in others [1]. Wollenberg
et al. [3] documented no benefit from intravenous penicillin. Our
patient reported a slight decrease of hyperpigmentation, but we were unable
to substantiate this effect. In circumscribed scleroderma the antiinfectious
effect of penicillin and the influence on the collagen metabolism after
conversion of penicillin to D-penicillamin have been discussed [25, 26].
In conclusion, there is so far no well-etablished therapeutic approach
to linear atrophoderma of Moulin.
Article accepted on 20/7/00
REFERENCES
1. Moulin G, Hill MP, Guillaud V, Barrut D, Chevallier J, Thomas
L. Bandes pigmentées atrophiques acquises suivant les lignes de
Blaschko. Ann Dermatol Venerol 1992; 119: 729-36.
2. Baumann L, Happle R, Plewig G, Schirren CG. Atrophodermia
linearis Moulin. Hautarzt 1994; 45: 231-6.
3. Wollenberg A, Baumann L, Plewig G. Linear Atrophoderma of
Moulin: a disease which follows Blaschko`s lines. Br J Dermatol
1996; 135: 277-9.
4. Artola Igarza JL, Sanchez Conejo-Mir J, Corbí Llopis
MR, Linares Barrios M, Casals Andreu N, Navarete Ortega M. Linear atrophoderma
of Moulin: treatment with Potaba. Dermatology 1996; 193: 345-7.
5. Cecchi R, Giomi A. Linear atrophoderma of Moulin. Acta
Derm Venereol 1997; 15: 77.
6. Hauser C, Skaria A, Harms M, Saurat JH. Morphea following
Blaschko`s lines. Br J Dermatol 1996; 143: 594-5.
7. Tajima S, Sakuraoka K. A case of atrophoderma of Pasini and
Pierini: Analysis of glycosaminoglycan of the lesional skin. J Dermatol
1995; 22: 767-9.
8. Braun RP, Saurat JH. A case of linear atrophoderma of Moulin.
J Dermatol 1996; 23: 660.
9. Wakelin SH, James MP. Zosteriform atrophoderma of Pasini and
Pierini. Clin Exp Dermatol 1995; 20: 244-6.
10. Grunwald MH, Peretz E, Halevy S. Guess What! Atrophoderma
of Pasini and Pierini. Eur J Dermatol 1998; 8: 135-6.
11. Altmeyer P, Adam B, Bacharach-Buhles M, Goerz G, Kind P,
Wirth G, Goertz J, Holzmann H, Gati-Fabry A, Staudt R, Mensing H, Krieg
T, Gerstmeyer J. Zur Klassifikation der zirkumskripten Sklerodermie. CCS:
Multizentrische Untersuchung an 286 Patienten. Hautarzt 1990; 41:
16-21.
12. Wokalek H, Schmidt HG, Niedner R, Conraths H. Atrophodermia
idiopathica progressiva Pasini-Pierini mit Vorkommen von antinukleären
Antikörpern. Hautarzt 1985; 36: 154-60.
13. Vale E, Gerstmeier H, Meurer M, Krieg T, Braun-Falco O. Spektrum
antinukleärer Antikörper bei zirkumskripten Formen der Sklerodermie.
Dtsch Med Wochenschr 1986; 111: 1922-7.
14. Lohrer R, Barran L, Kellnar St, Belohradsky BH. Atrophodermia
idiopathica et progressiva Pasini et Pierini, eine wenig bekannte Form
der zirkumskripten Sklerodermie im Kindesalter. Monatsschr Kinderheilkd
1986; 134: 878-80.
15. Thiel W, Schaarschmidt H, Wätzig V. Kasuistischer Beitrag
zum Krankheitsbild der Atrophodermia progressiva Pasini-Pierini. Dermatol
Monatsschr 1985; 171: 185-91.
16. Murphy PK, Hymes SR, Fenske N. Concomitant unilateral idiopathic
atrophoderma of Pasini and Pierini (IAPP ) and morphea. Int J Dermatol
29: 281-3.
17. Salamon W, Milicevic M. Über vier Fälle der idiopathischen
Atrophodermie von Pasini und Pierini. Dermatologica 1968; 136:
479-88.
18. Rupec M. Über die Beziehungen der zircumskripten Sklerodermie
zum Morbus Pasini-Pierini. Z Haut Geschlechtskr 1962; 33: 114-8.
19. Björngren H, Holst R. Reticulate hyperpigmentation of
Iijima, Naito and Uyeno: a European case. Acta Derm Venereol 1991;
71: 248-50.
20. Kalter C, Griffiths W, Atherton D. Linear and whorled nevoid
hypermelanosis. J Am Acad Dermatol 1988; 19: 1037-44.
21. Lee HJ, Kang WH, Hann SK. Acquired Blaschko dermatitis: acquired
relapsing self-healing Blaschko dermatitis. J Dermatol 1996; 23:
639-42.
22. Giamoni R, Restano L, Grimalt R. Lichen striatus - a chameleon:
An histopathological and immunological study of forty-one cases. J
Cutan Pathol 1995; 22: 18-22.
23. Grosshans EM. Acquired blaschkolinear dermatoses. Am J
Med Gen 1999; 85: 334-7.
24. Moss C. Cytogenetic and molecular evidence for cutaneous
mosaicism: the ectodermal origin of Blaschko lines. Am J Med Gen
1999; 85: 330-3.
25. Buechner SA, Rufli T. Morphaea profunda. Hautarzt
1990; 41: 155-7.
26. Schulze K, Herrmann K, Haustein U-F, Krusche U, Rothenburger
I. Einfluß von Penicillin und D-Penicillamin auf die ß-Galactosidaseaktivität
bei Patienten mit progressiver Sklerodermie. Dermatol Monatsschr
1988; 174: 661-6.
|